6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Clearmind Medicine Inc.
Filed: September 13, 2023
Period of Report: September 13, 2023
Accession Number: 0001213900-23-076255

View Document ↗ View on SEC.gov ↗